Nestle Health Science US Holdings Inc. 13D and 13G filings for Seres Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-07-22 1:34 pm Sale |
2022-07-18 | 13D | Seres Therapeutics, Inc. MCRB |
Nestle Health Science US Holdings Inc. | 7,594,038 6.100% |
-298,852 (-3.79%) |
Filing |
| 2020-08-19 5:17 pm Purchase |
2020-08-17 | 13D | Seres Therapeutics, Inc. MCRB |
Nestle Health Science US Holdings Inc. | 7,892,890 8.800% |
993,689 (+14.40%) |
Filing |